Low Levels of Unmodified Insulin Glargine in Plasma of People With Type 2 Diabetes Requiring High Doses of Basal Insulin

Lucidi Paola; Porcellati Francesca; Yki-Jarvinen Hannele; Riddle Matthew C.; Candeloro Paola; Andreoli Anna Marinelli; Bolli Geremia B.; Fanelli Carmine G.

首页> 外文期刊>Diabetes care >Low Levels of Unmodified Insulin Glargine in Plasma of People With Type 2 Diabetes Requiring High Doses of Basal Insulin

【24h】

Low Levels of Unmodified Insulin Glargine in Plasma of People With Type 2 Diabetes Requiring High Doses of Basal Insulin

机译：要求高剂量基础胰岛素的2型糖尿病患者血浆中未修饰的甘精胰岛素水平低

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Diabetes care》 |2015年第7期|共2页
作者
Lucidi Paola; Porcellati Francesca; Yki-Jarvinen Hannele; Riddle Matthew C.; Candeloro Paola; Andreoli Anna Marinelli; Bolli Geremia B.; Fanelli Carmine G.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词

相似文献

外文文献
中文文献
专利

1. Low Levels of Unmodified Insulin Glargine in Plasma of People With Type 2 Diabetes Requiring High Doses of Basal Insulin [J] . Lucidi Paola, Porcellati Francesca, Yki-Jarvinen Hannele, Diabetes care . 2015,第7期

机译：要求高剂量基础胰岛素的2型糖尿病患者血浆中未修饰的甘精胰岛素水平低
2. Insulin Degludec 200 Units/mL Is Associated With Lower Injection Frequency and Improved Patient-Reported Outcomes Compared With Insulin Glargine 100 Units/mL in Patients With Type 2 Diabetes Requiring High-Dose Insulin [J] . Mark L. Warren, Louis B. Chaykin, Serge Jabbour, Clinical diabetes . 2017,第2期

机译：与需要大剂量胰岛素治疗的2型糖尿病患者相比，胰岛素Degludec 200单位/ mL与较低的注射频率和改善的患者报告结果相关，与胰岛素甘草碱100单位/ mL相比
3. Reduced risk of hypoglycemia with insulin degludec versus insulin glargine in patients with type 2 diabetes requiring high doses of basal insulin: A meta-analysis of 5 randomized begin trials [J] . RodbardH.W., GoughS., LaneW., Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists . 2014,第4期

机译：需要高剂量基础胰岛素的2型糖尿病患者使用地高胰岛素和甘精胰岛素降低低血糖的风险：一项5项随机试验的荟萃分析
4. Switching to insulin glargine 300 U/mL from other basal insulin analogues provides less 24-hour glucose variability in hospitalized patients with type 1 diabetes [C] . V.V. Klimontov, E.A. Koroleva, O.N. Fazullina International Multiconference Bioinformatics of Genome Regulation and StructureSystems Biology . 2018

机译：从其他基础胰岛素类似物转换为甘精胰岛素300 U / mL可使住院的1型糖尿病患者的24小时葡萄糖变异性降低
5. Physiology and pharmacology of diabetes therapies in the cat: Insulin detemir, insulin glargine, exenatide and the incretin effect. [D] . Gilor, Chen. 2010

机译：猫的糖尿病疗法的生理和药理作用：地特胰岛素，甘精胰岛素，艾塞那肽和肠降血糖素作用。
6. Insulin Degludec 200 Units/mL Is Associated With Lower Injection Frequency and Improved Patient-Reported Outcomes Compared With Insulin Glargine 100 Units/mL in Patients With Type 2 Diabetes Requiring High-Dose Insulin [O] . Mark L. Warren, Louis B. Chaykin, Serge Jabbour, 2017

机译：与需要大剂量胰岛素治疗的2型糖尿病患者相比胰岛素Degludec 200单位/ mL与较低的注射频率和改善的患者报告结果相关与胰岛素甘草碱100单位/ mL相比
7. Low Levels of Unmodified Insulin Glargine in Plasma of People With Type 2 Diabetes Requiring High Doses of Basal Insulin: Figure 1 [O] . Paola Lucidi, Francesca Porcellati, Hannele Yki-Järvinen, 2015

机译：患有高剂量基础胰岛素的糖尿病血浆中血浆中低水平的未经修饰的胰岛素狼氨酸，需要高剂量的基础胰岛素：图1

Low Levels of Unmodified Insulin Glargine in Plasma of People With Type 2 Diabetes Requiring High Doses of Basal Insulin

著录项

相似文献

相关主题

期刊订阅